Missed Cancer Diagnoses: A Silent Crisis – The Institute of Cancer and Crisis
The Institute of Cancer and Crisis (ICC) shared a post on LinkedIn about a paper by Todd Burus et al. published in JAMA Oncology:
“Missed Cancer Diagnoses: A Silent Crisis.
A study published in JAMA Oncology estimated that over 134,000 cancer diagnoses were missed in the United States during the first 10 months of the COVID-19 pandemic. Screening programs, diagnostic procedures, and treatments were significantly delayed – putting lives at risk.
13% decline in cancer diagnoses
These delays mean that many patients are now being diagnosed at more advanced stages, making treatment more challenging. How can we build a healthcare system that ensures early detection, even in times of crisis?
At ICC, we are committed to addressing the intersection of cancer and crisis, advocating for stronger healthcare resilience and early detection strategies.
What lessons should we take from this crisis to prevent future setbacks in cancer care? Let’s start the conversation.”
“Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic”
Authors: Todd Burus, Feitong Lei, Bin Huang, Thomas Tucker, Krystle Lang Kuhs et al.
More posts featuring ICC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023